23 May 2018

Allied Minds plc (the "Company")

Annual General Meeting

Allied Minds plc, an IP commercialisation company focused on early stage company creation and development within the technology and life science sectors, is holding its Annual General Meeting (AGM) today.  No new information on current trading will be given during the meeting.

Allied Minds remains focused on delivering against its strategic objectives: accelerating the path to commercialisation and monetisation at its subsidiaries; and increasing the number of high quality new investments. Actions undertaken in 2017 have materially strengthened the portfolio and all subsidiaries continue to make good progress against published milestone objectives. Discussions with potential strategic investors and commercial partners for STT continue to progress positively.

The Company will release its 2018 Half Yearly Report on 16 August 2018.

About Allied Minds

Allied Minds plc (Allied Minds or the Company or the Group) is an IP commercialisation company focused on early stage company creation and development within the technology and life science sectors. With origination relationships spanning US federal laboratories, universities, and leading US corporations, Allied Minds sources, operates and funds a portfolio of companies to generate long-term value for its investors and stakeholders. Based in Boston, Allied Minds supports its businesses with capital, management, expertise and shared services. For more information, please visit www.alliedminds.com.

For more information, please contact:

Allied Minds plc                                               Available via corporate brokers / PR below

Peter Dolan, Chairman

Credit Suisse International                         +44 20 7888 8888

Lewis Burnett

Numis Securities                                             +44 20 7260 1000

Ben Stoop

FTI Consulting                                                   +44 20 3727 1000

Ben Atwell / Brett Pollard